Molecular mechanisms in the antiproliferative action of taxol and tiazofurin

E. Oláh, Bela Csokay, Noemi Prajda, Zsofia Kote-Jarai, Y. Albert Yeh, George Weber

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The molecular antiproliferative effects of taxol and tiazofurin were studied in human K562 leukemia and in MCF-7 breast and OVCAR-5 ovarian carcinoma cell cultures. A single treatment with taxol (2 to 100 nM) or tiazofurin (5 to 20 μM) on K562 leukemia cells resulted in both differentiation program and apoptosis in the same cell culture. Tiazofurin proved to be the most potent inducer of differentiation among the inducers, however, taxol had a major impact on induction of the alterations characteristics of apoptosis. The antiproliferative effect of tiazofurin was mediated by 37 to 85% inhibition of IMP dehydrogenase activity. Both the differentiation and apoptosis induced by tiazofurin were dependent on GTP supply. The induction of differentiation and/or apoptosis was mediated by downregulation of c-myc and Ki-ras oncogenes in all three cell lined treated with tiazofurin (by 2 hr) or taxol (by 24 hr). Combined treatments with tiazofurin and taxol exerted a schedule-dependent, antiproliferative interaction in the cell lines studied. Synergistic inhibition of cell proliferation was observed when cells were pretreated with tiazofurin (10 to 15 μM) for at least 12 hr, then taxol (5 to 15 nM) was added.

Original languageEnglish
Pages (from-to)2469-2477
Number of pages9
JournalAnticancer Research
Volume16
Issue number5 A
Publication statusPublished - Sep 1996

Fingerprint

tiazofurin
Paclitaxel
Apoptosis
Leukemia
Cell Culture Techniques
IMP Dehydrogenase
ras Genes
K562 Cells
Guanosine Triphosphate
Appointments and Schedules
Breast

Keywords

  • Apoptosis
  • Differentiation
  • K562
  • MCF-7
  • OVCAR-5
  • Schedule dependency
  • Taxol
  • Tiazofurin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Oláh, E., Csokay, B., Prajda, N., Kote-Jarai, Z., Yeh, Y. A., & Weber, G. (1996). Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Research, 16(5 A), 2469-2477.

Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. / Oláh, E.; Csokay, Bela; Prajda, Noemi; Kote-Jarai, Zsofia; Yeh, Y. Albert; Weber, George.

In: Anticancer Research, Vol. 16, No. 5 A, 09.1996, p. 2469-2477.

Research output: Contribution to journalArticle

Oláh, E, Csokay, B, Prajda, N, Kote-Jarai, Z, Yeh, YA & Weber, G 1996, 'Molecular mechanisms in the antiproliferative action of taxol and tiazofurin', Anticancer Research, vol. 16, no. 5 A, pp. 2469-2477.
Oláh E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA, Weber G. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Research. 1996 Sep;16(5 A):2469-2477.
Oláh, E. ; Csokay, Bela ; Prajda, Noemi ; Kote-Jarai, Zsofia ; Yeh, Y. Albert ; Weber, George. / Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. In: Anticancer Research. 1996 ; Vol. 16, No. 5 A. pp. 2469-2477.
@article{cff674c4ee5046b79c91ae745d5b3799,
title = "Molecular mechanisms in the antiproliferative action of taxol and tiazofurin",
abstract = "The molecular antiproliferative effects of taxol and tiazofurin were studied in human K562 leukemia and in MCF-7 breast and OVCAR-5 ovarian carcinoma cell cultures. A single treatment with taxol (2 to 100 nM) or tiazofurin (5 to 20 μM) on K562 leukemia cells resulted in both differentiation program and apoptosis in the same cell culture. Tiazofurin proved to be the most potent inducer of differentiation among the inducers, however, taxol had a major impact on induction of the alterations characteristics of apoptosis. The antiproliferative effect of tiazofurin was mediated by 37 to 85{\%} inhibition of IMP dehydrogenase activity. Both the differentiation and apoptosis induced by tiazofurin were dependent on GTP supply. The induction of differentiation and/or apoptosis was mediated by downregulation of c-myc and Ki-ras oncogenes in all three cell lined treated with tiazofurin (by 2 hr) or taxol (by 24 hr). Combined treatments with tiazofurin and taxol exerted a schedule-dependent, antiproliferative interaction in the cell lines studied. Synergistic inhibition of cell proliferation was observed when cells were pretreated with tiazofurin (10 to 15 μM) for at least 12 hr, then taxol (5 to 15 nM) was added.",
keywords = "Apoptosis, Differentiation, K562, MCF-7, OVCAR-5, Schedule dependency, Taxol, Tiazofurin",
author = "E. Ol{\'a}h and Bela Csokay and Noemi Prajda and Zsofia Kote-Jarai and Yeh, {Y. Albert} and George Weber",
year = "1996",
month = "9",
language = "English",
volume = "16",
pages = "2469--2477",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 A",

}

TY - JOUR

T1 - Molecular mechanisms in the antiproliferative action of taxol and tiazofurin

AU - Oláh, E.

AU - Csokay, Bela

AU - Prajda, Noemi

AU - Kote-Jarai, Zsofia

AU - Yeh, Y. Albert

AU - Weber, George

PY - 1996/9

Y1 - 1996/9

N2 - The molecular antiproliferative effects of taxol and tiazofurin were studied in human K562 leukemia and in MCF-7 breast and OVCAR-5 ovarian carcinoma cell cultures. A single treatment with taxol (2 to 100 nM) or tiazofurin (5 to 20 μM) on K562 leukemia cells resulted in both differentiation program and apoptosis in the same cell culture. Tiazofurin proved to be the most potent inducer of differentiation among the inducers, however, taxol had a major impact on induction of the alterations characteristics of apoptosis. The antiproliferative effect of tiazofurin was mediated by 37 to 85% inhibition of IMP dehydrogenase activity. Both the differentiation and apoptosis induced by tiazofurin were dependent on GTP supply. The induction of differentiation and/or apoptosis was mediated by downregulation of c-myc and Ki-ras oncogenes in all three cell lined treated with tiazofurin (by 2 hr) or taxol (by 24 hr). Combined treatments with tiazofurin and taxol exerted a schedule-dependent, antiproliferative interaction in the cell lines studied. Synergistic inhibition of cell proliferation was observed when cells were pretreated with tiazofurin (10 to 15 μM) for at least 12 hr, then taxol (5 to 15 nM) was added.

AB - The molecular antiproliferative effects of taxol and tiazofurin were studied in human K562 leukemia and in MCF-7 breast and OVCAR-5 ovarian carcinoma cell cultures. A single treatment with taxol (2 to 100 nM) or tiazofurin (5 to 20 μM) on K562 leukemia cells resulted in both differentiation program and apoptosis in the same cell culture. Tiazofurin proved to be the most potent inducer of differentiation among the inducers, however, taxol had a major impact on induction of the alterations characteristics of apoptosis. The antiproliferative effect of tiazofurin was mediated by 37 to 85% inhibition of IMP dehydrogenase activity. Both the differentiation and apoptosis induced by tiazofurin were dependent on GTP supply. The induction of differentiation and/or apoptosis was mediated by downregulation of c-myc and Ki-ras oncogenes in all three cell lined treated with tiazofurin (by 2 hr) or taxol (by 24 hr). Combined treatments with tiazofurin and taxol exerted a schedule-dependent, antiproliferative interaction in the cell lines studied. Synergistic inhibition of cell proliferation was observed when cells were pretreated with tiazofurin (10 to 15 μM) for at least 12 hr, then taxol (5 to 15 nM) was added.

KW - Apoptosis

KW - Differentiation

KW - K562

KW - MCF-7

KW - OVCAR-5

KW - Schedule dependency

KW - Taxol

KW - Tiazofurin

UR - http://www.scopus.com/inward/record.url?scp=0029909347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029909347&partnerID=8YFLogxK

M3 - Article

C2 - 8917337

AN - SCOPUS:0029909347

VL - 16

SP - 2469

EP - 2477

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 A

ER -